Growing community of inventors

Shanghai, China

Lingdong Zhu

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Lingdong ZhuFeng Ren (1 patent)Lingdong ZhuXichen Lin (1 patent)Lingdong ZhuTing Yang (1 patent)Lingdong ZhuHongfu Lu (1 patent)Lingdong ZhuWeichun Chen (1 patent)Lingdong ZhuZhongmiao Xu (1 patent)Lingdong ZhuEbere F Igboko (1 patent)Lingdong ZhuPaul Bryan Wren (1 patent)Lingdong ZhuWeichun Chen (0 patent)Lingdong ZhuXichen Lin (0 patent)Lingdong ZhuLingdong Zhu (1 patent)Feng RenFeng Ren (23 patents)Xichen LinXichen Lin (22 patents)Ting YangTing Yang (8 patents)Hongfu LuHongfu Lu (7 patents)Weichun ChenWeichun Chen (4 patents)Zhongmiao XuZhongmiao Xu (4 patents)Ebere F IgbokoEbere F Igboko (2 patents)Paul Bryan WrenPaul Bryan Wren (2 patents)Weichun ChenWeichun Chen (0 patent)Xichen LinXichen Lin (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)


1 patent:

1. 10106515 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…